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Blood pressure determinants in living—related renal allograft donors
and recipients. We studied 99 living related allograft donors with
follow—up information of at least 10 years and the 50 recipients who had
successful outcomes. Recipients were younger and had significantly
lower blood pressures at follow—up than their donors. Borderline and
definite hypertension were present in 22.2% and 4.0% of donors prior to
donation, in 14.4% and 21.1% of donors at follow—up, and in 2.0% and
18.0% of the 50 recipients at follow—up. Age, relative weight, and mean
arterial pressure (MAP) prior to donation were the key variables in
predicting the follow—up ranked MAP of the donors. CPAH prior to
donation was inversely correlated with the age of the donors and,
indirectly, with the follow—up MAP. Donor CPAH prior to donation was
significantly correlated with the renal allograft function of the recipients
but not with the recipient ranked MAP at follow—up. No correlation of
the ranked MAP or blood pressure outcome categories between donors
and recipients was found. We conclude that donation of one kidney can
accelerate the development of hypertension in those donors with
predisposition to develop hypertension. In addition, the predisposition
of the donors to develop hypertension and their age, within the range
observed in the study, does not significantly influence the long—term
blood pressure status of the recipient.
In recent years, transplant physicians have paid increasing
attention to several observations made in experimental animals:
1) extensive renal ablation leads to hypertension, progressive
proteinuria, glomerulosclerosis, and renal failure [1, 21; 2)
unilateral nephrectomy aggravates the course of hypertension
in spontaneously hypertensive rats [3, 4]; and 3) hypertension
can be transmitted from spontaneously hypertensive to normo-
tensive rats by renal transplantation [5—7]. These observations
may have important implications for living—related renal al-
lograft donors and their recipients.
Although several long—term follow—up studies of living—
related renal allograft donors have shown that their renal
function remains stable 10 to 20 years after kidney donation, a
sizable proportion of them develop hypertension [8—12]. In
renal allograft recipients, hypertension can be due to the
presence of native pressor kidneys, transplant renal artery
stenosis, chronic rejection, de novo or recurrent renal disease,
and administration of high—dose glucocorticosteroids or cyclo-
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sporin. In addition, an undetermined proportion of renal a!-
lograft recipients, without these recognized causes of hyperten-
sion, develop hypertension years after renal transplantation [13,
141.
Whether renal mass reduction contributes to the develop-
ment of hypertension in renal allograft donors or recipients with
solitary kidneys is unsettled. Similarly, it is uncertain whether
the hypertension of these donors or recipients merely repre-
sents essential hypertension. The role of factors such as sex,
age, and obesity, known to influence the course of essential
hypertension, is not known in the context of renal transplanta-
tion or donation.
We studied 99 allograft donors with follow—up of at least 10
years and the subset of their recipients who had successful
outcomes. We related their current blood pressure values with
factors known to influence blood pressure in the general popu-
lation, such as sex, age, and relative weight, as well as with
blood pressure values prior to renal transplantation, functional
characteristics of the transplanted kidney, maintenance steroid
dosages, and current renal function. We have attempted to
identify factors that might, prior to kidney donation or trans-
plantation, predict the future development of hypertension.
Finally, we have especially searched for a possible correlation
between the blood pressures of donors and recipients sharing
genetically identical kidneys which would support a primary
role for the kidney in the regulation of blood pressure and in the
development of hypertension.
Methods
Renal a/b graft donors
Between 1963 and 1973, 144 renal transplants from living
related donors had been performed at the Mayo Clinic. For the
purpose of the study, an attempt to contact all 144 donors was
made. Five donors had died of causes unrelated to the kidney
donation or to renal failure (malignancy 2, myocardial infarction
1, accidental death 1, Shy—Drager's syndrome 1). Thirty—nine
patients could not be contacted or refused to cooperate. One
hundred donors agreed to participate in the study. One donor
who had developed proteinuria, mild renal insufficiency, a
monoclonal kappa immunoglobulin fragment in serum and in
urine, and biopsy—proven kappa light—chain deposition disease
was excluded. The data for the study were abstracted from the
1383
1384 Torres et a!
Table 1. Renal allograft donor data at donation and at follow-up
Matched donors Unmatched donors Donors who did not participate
N x SD Range N x SD Range N x SD Range
Data before donation
Age, yr 50 36.8 12.3 20—68 49 38.6 11.2 18—60 39 36.1 12.5 17—63
Mean arterial pressure, 50 94 9 68—112 49 95 9 77—113 39 94 9 791 12
mm Hg
Relative body weight 50 1,16 0.17 0.84—1.83 46 1.16 0.19 0.79—1.58 39 1.18 0.19 0.84—1.59
ml/min/1.73 m2 40 547 131 314—775 40 519 103 371—810 35 542 88 420-765
ml/min/1.73 m2 40 108 20 69—143 40 106 20 58—158 35 106 14 83—135
Filtration fraction, % 40 20.1 2.3 15.9—27.1 40 20.5 2.3 13.4—25.3 35 19.9 2.8 14—25
Serum creatinine, mg/dl 49 1.01 0.2 0.7—1.5 49 0.96 0.2 0.7—1.7 39 0.97 0.2 0.71.4
Data at follow—up
Age, yr 50 49.0 12.6 30—80 49 51.6 11.6 29—71
Mean arterial pressure, 42 97 11 77—127 48 97 9 77—119
mm Hg
Relative body weight 47 1.26 0.22 0.84—2.06 44 1.25 0.25 0.89—2.28
Serum creatinine, mg/dl 50 1.2 0.2 0.8—1.8 49 1.2 0.2 0.8—1.8
Proteinuria, mg/24 hrs 42 100 107 16—550 47 79 117 3—821
medical records or were specially obtained for the study as
described in detail elsewhere [12]. Not all of the data of interest
were available from the remaining 99 donors included in the
study (Table 1). Nine donors were willing to have blood drawn
at a local laboratory and mailed to the Mayo Clinic at no cost,
but failed to have their blood pressures measured. The
pretransplantation information collected on donors included
race, sex, age, height, body weight, blood pressure, serum
creatinine, clearances of inulin (C111) and paraaminohippuric
acid (CPAH), and filtration fraction. At follow—up, we obtained
their current age, body weight, blood pressure, serum creati-
nine, and 24-hour urinary protein excretion.
Renal allograft recipients
The medical records of the recipients of the kidneys from the
99 donors participating in the study were reviewed. All these
patients had had bilateral nephrectomy prior to or at the time of
the renal transplantation. Most of them have been followed in
our Renal Transplant Clinic at yearly intervals. Only 50 patients
with satisfactory (serum creatinine <2 mgldl) and stable (for at
least the most recent three years) renal allograft function were
included in the study. Forty—five recipients were excluded for
various reasons: diabetes mellitus (8), graft loss due to infection
or other complications (11), graft loss or progressive renal
insufficiency due to rejection (19), recurrent disease (4), trans-
plant renal artery stenosis (3). The remaining four recipients
have been lost to follow—up. Not all of the data of interest were
available from every recipient (Table 1). The information col-
lected included sex, age, height, and body weight at transplan-
tation, pretransplant blood pressures (before bilateral nephrec-
tomy predialysis and postdialysis and after bilateral nephrec-
tomy predialysis and postdialysis), and current height, body
weight, blood pressure, serum creatinine, short renal iothalam-
ate clearance (Ciothalamate), 24-hour urinary protein excretion,
and the maintenance dose of prednisone. In addition to predni-
sone, all the recipients were taking azathioprine but none were
on cyclosporine A. The blood pressures reported in the recip-
ients were measured in a sitting position, and when available,
the average of two or three separate readings was calculated.
Laboratory methods
Determinations of serum creatinine [15], urine protein con-
centrations [16], and CPAH, filtration fractions, and
Ciothalamate were measured using the protocols and methods well
established in our Chemistry and Renal Function Laboratories
[17].
Definitions
Mean arterial blood pressures were calculated as the diastolic
blood pressures plus one—third of the pulse pressures. This
value, expressed in mm Hg, will be hereafter referred to as
"MAP." At follow—up, there were some recipients and donors
on antihypertensive medication. To incorporate everyone in the
analysis of MAP at follow—up, we assigned a rank to each
patient. This rank will be hereafter referred to as "ranked
MAP." Those on antihypertensive medication were ranked
higher than anyone not on it, with increasing order according to
their MAP. Definite hypertension was defined as a systolic
pressure of 160 mm Hg or more or diastolic pressure of 95 mm
Hg or more, or if the person was on antihypertensive medica-
tion. Borderline hypertension was defined as a systolic pressure
below 160 mm Hg and diastolic pressure below 95 mm Hg, but
not both below 140mm Hg systolic and 90mm Hg diastolic [18].
Normotension was defined as both systolic blood pressure
<140 and diastolic <90 mm Hg. Both definitions of borderline
hypertension and of normotension required that the patient not
be on antihypertensive medications. The relative body weight is
the ratio of the actual weight over the ideal weight adjusted for
sex, height, and age on the basis of standard tables from the
Metropolitan Life Insurance Company. Obesity is defined as a
relative body weight of 1.2 or more.
Statistical analysis
The paired t-test and signed rank test were used to compare
results in donor—recipient pairs [19]. Two—sample t-tests were
used to compare independent groups. Rank correlations were
calculated to assess the degree of association between two
variables. Stepwise multiple linear regression analysis and
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Table 2. Data of matched renal—allograft donors and recipients at transplantation and at follow—up
Matched donors Matched recipients
valueaN x SD Range N x SD Range
Data before transplantation
50 36.8 12.3 20—68 50 30.4 12.5 13—58 0.014Age, yrs
Mean arterial pressure 50 94 9 68—112 49k' 117 16 87—148 <0.001
mm Hg
44C
35d
35e
113 19
102 14
98 15
81—147
80—134
63—131
<0.001
0.007
NS
Relative body weight 50 1.16 0.17 0.84-1.83 50 0.96 0.16 0.66—1.46 <0.001
CPAH, ml/min/1.73 m2 40 547 131 314—775 — — —
C1,,,,,,, ml/min/1,73 m2 40 108 20 69—143 — — — —
Filtration fraction 40 20 2 16—27 — — — —
Serum creatinine, mg/dl 49 1.0 0.2 0.7—1.5 — — — —
Data at follow—up
Age 50 49.0 12.6 30—80 50 43.3 12.5 26—71 0.036
Mean arterial pressure 42 97 11 77—127 50 92 9 72—114 0.018
mm Hg
Relative body weight 47 1.32 0.24 0.86—2.19 50 1.23 0,20 0.89—1.75 NS
Ciothalamate 47 71 20 21—104
mI/mm/i .73 m2
Serum creatinine, mg/dl 50 1.2 0.2 0.8—1.8 50 1.3 0.3 0.6—1.9 NS
Proteinuria, mg/24 hrs 42 100 107 16—550 46 238 321 16—1800 0.001
Maintenance prednisone — — — 50 7.4 2.5 5—15 —
dose, mg
a Two—tailed P-value from signed rank test. Compares recipients and donors on a matched basis using only those donor—recipient pairs where
both have the measurement. For mean arterial pressure, the four different situations for matched recipients prior to transplantation were all
compared to the matched controls pre-donation valuesb Predialysis before bilateral nephrectomy
Postdialysis before bilateral nephrectomy
ci Predialysis after bilateral nephrectomy
Postdialysis after bilateral nephrectomy
stepwise discriminant analysis with backward elimination of
variables which didn't achieve P = 0.05 level of significance
were used to assess the predictive value of the variables
recorded at transplantation on the donor ranked MAP at
follow—up or on the blood pressure outcome category, respec-
tively [201. In addition, we studied this latter outcome in
relation to a series of dependent variables using a binary—
branching classification—tree approach [211. This is a relatively
new, computer—intensive approach to obtain splits on variables
which results in subgroups of patients belonging to a single
blood pressure outcome category. The goal was to predict
donors' follow—up blood pressure category using information
obtained prior to transplant. Prior probabilities of being in a
hypertensive class were taken to be those observed in our data.
In assigning statistical losses (values between 0 and 1) associ-
ated with an incorrect prediction, it was considered most
serious (0.8) to predict as normotensive a donor who subse-
quently had definite hypertension, followed by a borderline
hypertensive who developed definite hypertension (0.6). Other
errors in prediction were given considerably less weight (<0.2).
Results
Table 1 compares the characteristics of the 39 donors who
were lost to follow—up or refused to participate in the study, the
donors for the 49 excluded recipients, and the donors for the 50
recipients included in the study. No differences between these
groups of donors were observed at baseline or at follow—up.
Fifty—two of the 99 (52.5%) donors participating in the study
were women. One donor was an American Indian, and the
remainder were Caucasian.
Table 2 compares the data of the matched, renal allograft
donors and recipients. The duration of follow—up was similar.
Renal allograft recipients were significantly younger than their
donors. Renal allograft donors had significantly—higher relative
weight than recipients prior to renal transplantation, but this
difference disappeared following renal transplantation.
With the exception of the blood pressures obtained after
bilateral nephrectomy and dialysis, the MAP of the allograft
recipients prior to renal transplantation was significantly higher
than that of their donors. At the time of last follow—up, MAP
was significantly higher in the donors while no significant
difference in mean serum creatinine concentration was de-
tected. The follow—up proteinuria was significantly higher in the
recipients.
The relative weight of the donors and of the recipients prior
to donation was significantly correlated with their follow—up
relative weight as shown in Figure 1. As a group, there was a
significant weight gain in the donors between the time of
donation and the time of follow—up. Individually, however, the
weight gain tended to be more pronounced in the donors who
were already overweight at donation, as reflected by the donor
regression line in Figure 1 which is significantly different from
the identity line (P < 0.0001).
At donation, 22 (22.2%) and four (4.0%) of the 99 donors had
borderline and definite hypertension respectively with no one
on antihypertensive medication. At follow—up, the frequencies
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Fig. 2. Frequency of borderline (light bar) and definite hypertension(dark bar) in renal allograft donors at donation (upper panel) and
follow—up (lower panel) per decade of age. Overall frequencies are
indicated adjacent to the circles. The data for the U.S. white population
(middle panel) are from the First Health and Nutrition Examination
Survey, USA, 1971—1974.
of borderline and definite hypertension in the 90 donors with
adequate blood—pressure information were 14.4% and 21.1%,
respectively. Of the 19 donors with definite hypertension at
follow—up, 16 were defined as such because they were taking
antihypertensive medications. Of these 16 patients, eight were
taking a single antihypertensive drug (5, diuretics; 2, beta
blockers; 1, alphamethyldopa), four were taking two drugs, and
four were using three antihypertensive medications. Despite the
use of antihypertensive drugs, only six of these 16 donors had
normal blood pressure readings. The frequencies of borderline
and definite hypertension by decade of age in the donors at
donation and at follow—up are presented as are those of the
general white U.S.A. population [21] in Figure 2. The one
Table 3. Rank correlations between the donor ranked mean arterial
blood pressures at follow—up and various donor parameters
r P N
Age at donation 0.46 <0.001 90
MAP at donation 0.42 <0.001 90
Relative weight at donation 0.38 <0.001 87
C1,1,,, at donation —0.24 0.043 73
CPAH at donation —0.33 0.005 73
Filtration fraction at donation 0.26 0.027 73
Serum creatinine at donation 0.09 NS 89
Relative weight at F/U 0.35 0.001 85
American Indian was normotensive prior to nephrectomy and
at last follow—up as was the recipient at follow—up. Donors with
definite hypertension at follow up were more likely to have had
borderline or definite hypertension at donation (chi—square, I
degree of freedom, 5.3, P 0.022). Of those 66 normotensive at
donation, 10 (15.2%) had definite hypertension at follow—up,
while of those 24 donors with borderline or definite hyperten-
sion at donation, 9 (37.5%) had definite hypertension at
follow—up. The sex of the donors had no significant influence on
the outcome of their blood pressure. The rank correlations
between the donor ranked MAP at follow—up and other donor
data are shown in Table 3. The ranked MAP at follow—up was
significantly correlated with age, MAP at donation, and with
relative weight at donation and at follow—up. CPAH and Clm
were inversely correlated not only to the ranked MAP at
follow—up (Table 3) but also to the age of the donors (CPAH and
age, r =
—0.58, P <0.001, N = 80).
Using data obtained at donation, a stepwise, multiple linear
regression analysis with backward elimination of variables
indicated that age, relative weight, and MAP at donation were
the key variables in predicting the donor's ranked MAP at
follow—up. CPAH, Cij, and filtration fraction, on the other
hand, were of no additional predictive value. Using a
binary—branching classification—tree approach, a single split on
age at donation was found to be a useful predictor of the
blood—pressure outcome category. Figure 3 illustrates the dis-
tribution of the donors in relation to the predictive split on this
variable and their blood—pressure outcome category. Relative
weight and MAP prior to donation are also included in Figure 3
as they were indicated in the stepwise regression analysis on the
ranks, although not supported in the internal crossvalidation of
the recursive partitioning analysis.
At follow—up, one (2%) of the 50 renal allograft recipients had
borderline hypertension and nine (18.0%) had definite hyper-
tension. Rank correlations between recipient ranked MAP at
follow—up and various donor and recipient data are shown in
Table 4. The ranked MAP of the recipients at follow—up was
significantly correlated only with their relative weight at trans-
plantation or at follow—up. The positive correlation between the
age and the ranked MAP of the recipients at follow—up did not
reach statistical significance. No correlation of the ranked
MAP of the recipients at follow—up with their current serum
creatinines, Ciothalamate or maintenance prednisone dose, or with
the C111i1 or CPAH of the donors at donation was observed.
Noteworthy is the lack of correlation between the ranked
MAP of the donors and the recipients at follow—up (Table 4).
Relative weight at Tx
Fig. 1. Scatter diagram of the relative body weights prior to transplan-
tation versus that at follow—up in the donors and the recipients. The
dashed line is the regression line while the solid line is the line of
identity.
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Table 4. Rank correlations between recipient ranked mean arterial pressures at follow—up and various donor and recipient parameters
Donor data Recipient data
r P Nr P N
Age at transplantation —0.03 NS 50 0.21 NS 50
MAP at transplantation 0.10
—
—
—
NS
—
—
—
50
—
—
—
0.08
0.08
0.03
0.09
NS
NS
NS
NS
49"
44b
353s
Relative weight at transplantation —0.24 NS 50 0.45 <0.001 50
C,,,,11,, at donation 0.09 NS 40 — — —
CPAH at donation 0.03 NS 40 — — —
Serum creatinine at donation —0.22 NS 49 — — —
Ranked MAP at F/U 0.17 NS 42 — — —
Relative weight at F/U —0.26 NS 44 0.56 <0.001 50
CiothaIamat at F/U — — — 0.12 NS 47
Serum creatinine at F/U —0.22 NS 50 0.08 NS 50
Prednisone dose at F/U — — — 0.12 NS 50
before bilateral nephrectomy
b Postdialysis before bilateral nephrectomy
Predialysis after bilateral nephrectomy
d Postdialysis after bilateral nephrectomy
Table 5. Blood pressure status category of the donors vs. their
recipients at follow—up
Recipients
Normal
blood
pressure
Borderline
hyper-
tension
Definite
hyper-
tension Total
Donors
BP not obtained 7 0 1 8
Normal BP 21 0 5 26
Borderline hypertension 5 0 1 6
Definite hypertension 7 1 2 10
Total 40 1 9 50
The lack of association between the blood pressure status
categories of the recipients and their donors at follow—up is
shown in Table 5. Seven recipients from donors with definite
hypertension at follow up had normal blood pressures. Their
mean relative weight (1.29 0.22, mean SD), although lower,
was not significantly different from that of their donors (1.42
0.34). Five recipients from donors with normal blood pressure
had definite hypertension at follow—up. Their relative weight
(1.41 0.24) was significantly higher (P = 0.023) than that of
their donors (1.05 0.17). The relative weight of the 10 donors
with definite hypertension at follow—up (1.35 0.30) was higher(P = 0.086) than that of the donors with normal blood pressures
at follow—up (1.20 0.19). The relative weight of the nine
recipients with definite hypertension at follow—up (1.36 0.22)
was significantly higher (P = 0.030) than that of the recipients
with normal blood pressure at follow—up (1.20 0.19). The
maintenance dose of prednisone of the nine recipients with
definite hypertension at follow—up (6.9 2.1 mg) was not
different from that of the recipients with normal blood pressure
at follow—up (7.6 2.6 mg).
While the recipient ranked MAP at follow—up is seemingly
independent of the donor characteristics analyzed in this study,
the renal allograft function was not. Rank correlations between
Table 6. Rank correlations between recipient renal function
parameters at follow—up and various donor and recipient data
Recipient measurements at follow—up
lothalamate
clearance Serum creatinine
r P N r P N
Donor data
Age at donation —0.67 <0.001 47 0.49 <0,001 50
CPAH at donation 0.41 0.01 37 —0.37 0.02 40
C,,,.,,1, at donation 0.29 NS 37 —0.29 NS 40
Serum creatinine at 0.02 NS 47 —0.03 NS 49
donation
Ranked MAP at F/U —0.24 NS 39 0.23 NS 42
Serum creatinine at F/U —0.15 NS 47 0.25 NS 50
Proteinuria at F/U —0.07 NS 39 0.20 NS 42
Recipient data
Months after transplan- 0.02 NS 47 0.02 NS 50
tation
Age at transplantation 0.16 NS 47 0.25 NS 50
Ranked MAP at F/U 0.12 NS 47 0.08 NS 50
Relative weight at F/U 0.08 NS 47 0.01 NS 50
Weight change, (F/U- 0.04 NS 47 0.01 NS 50
donation, kg)
Prednisone dose at F/U —0.44 0.002 47 0.39 0.005 50
the recipient serum creatinines and Ciothalamate at follow—up and
various donor and recipient data are shown in Table 6. The level
of renal allograft function, reflected by the serum creatinine or
Ciothalamate, was negatively correlated to the age of the donors
and positively correlated to the donor CPAH at donation. Inter-
estingly, the level of renal function was also negatively corre-
lated with the maintenance dose of prednisone, which probably
reflects the reluctance of the attending physicians to reduce the
dose of prednisone in those patients with lower levels of renal
function. Noteworthy is the lack of correlation between renal
allograft function and the age of the recipients or the time since
transplantation.
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Discussion
Observations in experimental animals, especially in the rat,
have raised some concern on the long—term stability of renal
function after donation of one kidney [1, 2]. Several long—term
follow—up studies of renal allograft donors have recently con-
firmed that their renal function remains stable 10 to 20 years
after renal donation [8—12]. Some of these studies, however,
have called attention to the relatively high prevalence of hyper-
tension in these patients [9—12]. The renal allograft donors are a
special population. On the one hand they have been selected in
part because of their normal blood pressures. On the other
hand, their risk for hypertension may be increased because of
familial genetic factors predisposing them to hypertension or
renal disease. Additionally, the risk might be further enhanced
by the tissue matching procedure used to select one from two or
more potential donors. Therefore, to reach a decisive conclu-
sion on whether the nephrectomy increases the risk of the
donors to develop hypertension, it would be necessary, a!-
though very difficult, to study a control population matched for
sex, age, and relation to the renal allograft recipients.
We have not studied an "adequate control" population to
determine whether the frequency of hypertension in the renal
allograft donors has been influenced by the donation of the
kidney, Nevertheless, several observations made in Figure 2
are of interest. As expected because of selection biases against
hypertensive donors, the frequency of hypertension in the renal
allograft donors prior to nephrectomy is lower than in the
general population while that of borderline hypertension is not.
This indicates that individuals with borderline hypertension had
been readily accepted as renal allograft donors. The frequency
of definite hypertension at follow—up, 10 to 20 years after
kidney donation, remains lower than that in the general popu-
lation for the donors in the lower age groups (25 to 54 years of
age), whereas in the older age groups (over 55 years of age) it is
similar to that in the general population. Considering the
percent increase in definite hypertension from one age group to
the next, the development of hypertension after donor nephrec-
tomy seems to occur at a faster rate than would be seen in the
general population. The percent increase of combined border-
line and definite hypertension from one age group to the next,
however, does not seem to be higher. Furthermore, the percent
increase of the combined borderline and definite hypertension
from the time of donation (mean age 37.7 years) to the time of
the last follow—up (mean age 50.3 years), that is, from 26.4% to
35.5%, is less than the increase noted in the general population
from 29.7% in the 35 to 44-year—old age group to 45.9% in the 45
to 54-year--old age group. The directional changes in the fre-
quency of borderline as compared to definite hypertension
between the time of donation and the time of the last follow—up,
that is, a reduction in the frequency of borderline as compared
to definite hypertension, resemble similar directional changes in
the general population. These observations are consistent with
the interpretation that the donation of one kidney may acceler-
ate the development of definite hypertension in patients with a
pre-existing disposition to the development of hypertension.
This conclusion is supported by our data showing that the renal
allograft donors with definite hypertension 10 to 20 years after
donor nephrectomy were more likely to have had borderline or
definite hypertension prior to donation of the kidney. These
observations in man are consistent with previous observations
in rats with spontaneous hypertension in which unilateral
nephrectomy results in an accelerated development and aggra-
vated course of hypertension [3, 4].
The concept that hypertension develops in renal allograft
donors with a pre-existing disposition towards hypertension is
further supported by the analysis of the variables that have an
independent significant association with the rank of donor MAP
at follow—up. These were age, relative weight, and blood
pressure prior to donation. These factors are well known to
have an effect on the course of essential hypertension in man
[22]. On the other hand, the association of the renal function
parameters, CJm and CPAH, prior to donation and ranked
donor MAP at follow—up is probably explained by the correla-
tion that existed between these parameters and the age of the
donors at donation. This is supported by the multiple regression
analysis of predictors of donor ranked MAP at follow—up where
age was a highly significant factor, while the clearances were
not significant once age was included in the model. This
conclusion is also supported by the fact that the predonation
renal clearances were not correlated with the ranked MAP of
the recipients at follow—up.
Using a stepwise discriminant analysis with backward elimi-
nation of variables and a binary—branching classification—tree
approach, we have used the independent variables prior to
donation to predict the donors blood pressure outcome cate-
gory (Fig. 3). The risk to develop definite hypertension 10 to 20
years after donation is negligible for those donors younger than
45 years of age who were normotensive (MAP of <100 mm Hg)
and not obese (relative weight of <1.20) at donation. On the
other hand, three out of seven (45.7%) donors older than 45
years who were normotensive and not obese at donation had
developed definite hypertension 10 to 20 years later. It is
possible that a similar proportion of younger kidney donors
might develop hypertension after more prolonged follow—up.
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Fig. 3. Blood pressure outcome category: (0) normal blood pressure,
(•) borderline hypertension, (A) definite hypertension) of the donors
depending on their relative weight, age, and MAP (<100, upper panel,
or 100 mmHg, lower panel) at transplantation.
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The possibility that the correlations between relative weights
and ranked MAP at follow—up in the donors could be
artifactual, due to a measurement error with overestimation in
obese persons of the blood pressures measured by an indirect
method in thick upper arms, should be considered. We believe
that this is unlikely. Within the range of moderate obesity in our
study, no consistent overestimation of blood pressure by the
indirect auscultatory method has been found by investigators
who have addressed this question [23, 24]. In the few cases with
very large arm circumferences, measurement errors would have
been minimized by the use of 18 centimeter wide cuffs [25], as
routinely used in these cases in our Renal Transplant Clinic.
The MAP of the recipients at follow—up was significantly
lower than that of the donors. These differences are probably
explained by the younger age of the recipients, although other
factors such as partial denervation of the kidney [26, 27], an
effect of the immunosuppressive therapy [28, 29], and better
blood—pressure control in those who have developed hyperten-
sion cannot be entirely excluded. The only variable that was
found to have a significant influence on the blood pressure of
the recipients at follow—up was their relative weight at trans-
plantation or at follow—up.
Despite the correlation found between the renal clearances of
the donor prior to donation and the renal function of the
recipients at follow—up (Table 6), no significant effect on blood
pressure was found (Table 4). Similarly, no correlation of MAP
or blood pressure outcome categories between the donors and
recipients was found. We are, therefore, unable to extend to
man the observations made by Dahl, Heine and Thompson [5],
Bianchi et al [6], and Kawabe et al [7] in different strains of
spontaneously hypertensive rats. These authors demonstrated
that hypertension can be transmitted from hypertensive to
normotensive animals by renal transplantation and that rats
with spontaneous hypertension could be made normotensive by
bilateral nephrectomy and transplantation of the kidney from a
normotensive animal. Our results do not negate the existence
of a genetically—determined renal factor of relevance to the
pathogenesis of essential hypertension, but suggest that other
extrarenal factors and possibly environmental factors are quan-
titatively more important in the pathogenesis of essential hy-
pertension in man.
Our results are not necessarily in contradiction with those
reported by Guidi et al [30]. These authors studied two small
groups of renal transplant recipients matched for age, sex, body
surface area, family history of hypertension, duration of
hemodialysis before transplantation, and original kidney dis-
ease. All the patients had had bilateral nephrectomies prior to
renal transplantation. One group received a renal allograft from
a cadaveric donor with a family history of hypertension,
whereas the second group received the kidney from a donor
without a family history of hypertension. Following renal
transplantation, the blood pressures were similar in both
groups, but the requirement for antihypertensive therapy was
greater in the first group during the first four months after
transplantation. This difference was not detectable beyond four
months, and the authors speculated that the loss of this "kidney
effect" might have been due to the predominance of other
extrarenal factors.
The concept of the primacy of the kidney in the pathogenesis
of essential hypertension in man has been supported by Curtis
et al in a carefully performed study [31]. These authors reported
the remission of essential hypertension after bilateral nephrec-
tomy and renal transplantation in six patients with renal failure
secondary to accelerated hypertension. Based on this observa-
tion, these authors concluded that the kidney had been primar-
ily at fault in the pathogenesis of the hypertension in their
patients, since the blood pressure remained normal following
bilateral nephrectomy and transplantation of a kidney from a
normotensive donor. There are at least two possible explana-
tions for the discrepancy between this study and our results.
First, it is possible that the patients studied by Curtis and
coworkers represent only a small subset of patients with severe
essential hypertension, and that the conclusions derived from
the study of these patients cannot be extrapolated to the larger
population of patients with benign essential hypertension. Sec-
ond, neither their nor our results exclude the possible existence
of important pathophysiologic interactions between the kidney
and other extrarenal factors, such as the sympathetic nervous
system or an immunologic factor which could be missing [32,
331 in the partially reinnervated allograft [26, 27] or in the
immunosuppressed patient [28, 29].
A detailed discussion of the risks of donation of a kidney for
renal transplantation is an essential part in the evaluation and
counseling of a potential living—related kidney donor. The
selection of a living—related or cadaveric donor with adequate
renal function is basic for the long—term satisfactory function of
the renal allograft. The analysis of the blood pressure determi-
nants in renal allograft donors and their recipients with success-
ful outcomes provides valuable and previously unavailable
information to the physicians involved in the counseling or
selection of kidney donors and in the care of their recipients.
Based on this information, we believe that potential kidney
donors should be told that the donation of one kidney can
accelerate the development or aggravate the course of hyper-
tension in those with a predisposition to develop hypertension,
that individuals with borderline hypertension should be advised
against kidney donation, and that maintenance of a relative
weight close to unity is advisable to reduce the risk of devel-
oping hypertension. These data further suggest that within the
range of ages and blood pressures of the donors included in this
study the age of the donors or their predisposition to develop
hypertension does not significantly influence the blood pressure
status of the recipients.
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